hcpcs data

J3262

Injection, tocilizumab, 1 mg

Medicare: Carrier judgmentJ seriesAdded January 01, 2011

What J3262 means

J3262 (Tocilizumab injection) belongs to the HCPCS Level II J series (Drugs Administered Other than Oral Method; Chemotherapy Drugs). Its Medicare coverage status is Carrier judgment. Medicare coverage is left to the judgment of the local Medicare Administrative Contractor (MAC), so check your MAC's local coverage determinations.

Part B pricing: Drugs.

Code details

Short description
Tocilizumab injection
Coverage code
C = Carrier judgment
Pricing indicator
51 = Drugs
Multiple pricing indicator
A = Not applicable as HCPCS priced under one methodology
Type of service
1 = Medical care P = Lump sum purchase of DME, prosthetics, orthotics
Action code
N = No maintenance for this code
Action effective date
January 01, 2011
Code added date
January 01, 2011
Data year
2026

Questions about J3262

What is HCPCS code J3262?

HCPCS code J3262 is a Level II code in the J series (Drugs Administered Other than Oral Method; Chemotherapy Drugs). Its full description is: "Injection, tocilizumab, 1 mg"

Is J3262 a CPT code?

No. J3262 is a HCPCS Level II code maintained by CMS, not a CPT (Level I) code from the American Medical Association. People often search for it as a CPT code because both code sets are reported on the same claims.

Does Medicare cover HCPCS code J3262?

The Medicare coverage code for J3262 is "Carrier judgment". Medicare coverage is left to the judgment of the local Medicare Administrative Contractor (MAC), so check your MAC's local coverage determinations.

When was HCPCS code J3262 added?

J3262 was added to the HCPCS code set on January 01, 2011. The most recent action on it (No maintenance for this code) took effect on January 01, 2011.

All J codes